Year archive

Active Biotech — 2010 filings

All 62 regulatory filings released by Active Biotech (ACTI) in 2010, sourced directly from the official regulator.

62 Filings

2010 Period

2010 filings (62)

Filing	Released	Lang
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-12-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-12-30	English
TEVA OCH ACTIVE BIOTECH OFFENTLIGGÖR FRAMGÅNGSRIKA FAS III-RESULTAT FÖR LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS Earnings Release FY 2010	2010-12-09	Swedish
TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY WITH ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS Earnings Release FY 2010	2010-12-09	English
Active Biotechs projekt 57-57 rekommenderat som särläkemedel Environmental & Social Information	2010-11-18	Swedish
Orphan Medicinal Product Status to Active Biotech's 57-57 project recommended Regulatory Filings	2010-11-18	English
Active Biotechs valberedning utsedd Board/Management Information	2010-11-03	Swedish
Active Biotech's election committee appointed AGM Information	2010-11-03	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-10-29	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-10-29	English
Interim / Quarterly Report 2010 Interim / Quarterly Report 9M 2010	2010-10-27	Swedish
Interim / Quarterly Report 2010 Interim / Quarterly Report 9M 2010	2010-10-27	English
NYA DATA SOM UTVÄRDERAR LAQUINIMIOD FÖR BEHANDLING AV MULTIPEL SKLEROS UPPVISAR NERVSKYDDANDE EFFEKTER Regulatory Filings	2010-10-15	Swedish
NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRATE NEUROPROTECTIVE EFFECTS Earnings Release FY 2010	2010-10-15	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-09-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-09-30	English
LAQUINIMOD I TABLETTFORM UPPVISAR BIBEHÅLLEN EFFEKT OCH SÄKERHET I PATIENTER MED MULTIPEL SKLEROS Regulatory Filings	2010-09-20	Swedish
ORAL LAQUINIMOD DEMONSTRATED SUSTAINED EFFICACY AND SAFETY IN PATIENTS WITH MULTIPLE SCLEROSIS Earnings Release FY 2010	2010-09-20	English
Active Biotech presenterar på UBS Global Life Sciences Conference Investor Presentation	2010-09-16	Swedish
Active Biotech to Present at the UBS Global Life Sciences Conference Investor Presentation	2010-09-16	English
Active Biotech presenterar på Rodman & Renshaw 12th Annual Healthcare Conference Regulatory Filings	2010-09-09	Swedish
Active Biotech to Present at the Rodman & Renshaw 12th Annual Healthcare Conference Investor Presentation	2010-09-09	English
Interim / Quarterly Report 2010 Interim / Quarterly Report H2 2010	2010-08-11	Swedish
Earnings Release 2010 Earnings Release H1 2010	2010-08-11	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-07-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-07-30	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-06-30	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-06-30	English
Active Biotechs kapitalmarknadsdag Report Publication Announcement	2010-06-10	Swedish
Active Biotech Capital Markets Day Investor Presentation	2010-06-10	English
Active Biotechs prostatacancerprojekt TASQ presenterat på ASCO Regulatory Filings	2010-06-07	Swedish
Active Biotech’s TASQ prostate cancer project presented at ASCO Regulatory Filings	2010-06-07	English
Active Biotechs prostatacancerprojekt presenteras på ASCO Regulatory Filings	2010-05-21	Swedish
Active Biotech's TASQ prostate cancer project to be presented at ASCO Legal Proceedings Report	2010-05-21	English
Active Biotechs njurcancerprojekt ANYARA presenteras i Journal of Immunotherapy Regulatory Filings	2010-05-18	Swedish
Active Biotech's Renal Cancer Project ANYARA Featured in Journal of Immunotherapy Regulatory Filings	2010-05-18	English
Active Biotechs prostatacancerprojekt TASQ presenteras i Molecular Cancer Regulatory Filings	2010-05-17	Swedish
Active Biotech's Prostate Cancer Project TASQ Featured in Molecular Cancer Regulatory Filings	2010-05-17	English
Årsstämma i Active Biotech AB AGM Information	2010-05-07	Swedish
Annual General Meeting of Active Biotech AB AGM Information	2010-05-07	English
Major Shareholding Notification 2010 Major Shareholding Notification	2010-04-30	English
Interim / Quarterly Report 2010 Interim / Quarterly Report Q1 2010	2010-04-22	Swedish
Interim / Quarterly Report 2010 Interim / Quarterly Report Q1 2010	2010-04-22	English
Annual Report 2009 Annual Report FY 2009	2010-04-20	Swedish
Annual Report 2009 Annual Report FY 2009	2010-04-20	English
Årsredovisning 2009 Active Biotech AB (publ) Report Publication Announcement	2010-04-20	Swedish
Annual Report 2009 Active Biotech AB (publ) Report Publication Announcement	2010-04-20	English
NYA DATA VISAR ATT LAQUINIMODS IMMUNMODULERANDE EFFEKT PÅ MULTIPEL SKLEROS ÄVEN KAN VARA NERVSKYDDANDE Regulatory Filings	2010-04-15	Swedish
NEW DATA SUGGEST ORAL LAQUINIMOD MAY CONFER NEUROPROTECTION IN ADDITION TO IMMUNOMODULATION IN THE TREATMENT OF MULTIPLE SCLEROSIS Earnings Release FY 2010	2010-04-15	English
Kallelse till årsstämma AGM Information	2010-04-06	Swedish
Notice of Annual General Meeting of Shareholders AGM Information	2010-04-06	English
Active Biotech tillförs 149 miljoner kronor genom en riktad nyemission Share Issue/Capital Change	2010-04-01	Swedish
Active Biotech raises SEK 149 million through a directed share issue Capital/Financing Update	2010-04-01	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-03-31	Swedish
Number of shares and votes in Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-03-31	English
Major Shareholding Notification 2010 Major Shareholding Notification	2010-03-02	English
Antal aktier och röster i Active Biotech Declaration of Voting Results & Voting Rights Announcements	2010-02-26	Swedish
Number of shares and votes in Active Biotech Share Issue/Capital Change	2010-02-26	English
Annual Report 2009 Annual Report FY 2009	2010-02-11	Swedish
Annual Report 2009 Annual Report FY 2009	2010-02-11	English
Explorativa data presenterade för Active Biotechs projekt ANYARA Regulatory Filings	2010-02-10	Swedish
Exploratory data presented for Active Biotech's ANYARA project Regulatory Filings	2010-02-10	English

Filings by year

2026 11 filings
2025 41 filings
2024 45 filings
2023 32 filings
2022 42 filings
2021 48 filings
2020 41 filings
2019 45 filings
2018 38 filings
2017 33 filings
2016 40 filings
2015 40 filings
2014 49 filings
2013 58 filings
2012 58 filings
2011 56 filings
2010 62 filings
2009 55 filings
2008 28 filings
2007 8 filings